日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/11/17 | 日証協 | 386,280株 | -8.35% | 40,900株 | +32.3% | 150,747株 | +23.19% | 141,368株 | +23.24% |
2017/11/10 | 日証協 | 421,494株 | +4.65% | 30,914株 | -65.54% | 122,369株 | +8.23% | 114,712株 | +27.45% |
2017/11/02 | 日証協 | 402,780株 | +2.81% | 89,706株 | -35.03% | 113,069株 | +44.04% | 90,006株 | +107.37% |
2017/10/27 | 日証協 | 391,774株 | +21.58% | 138,073株 | +206.35% | 78,497株 | -43.1% | 43,404株 | +145.47% |
2017/10/20 | 日証協 | 322,231株 | +2.34% | 45,070株 | -70.34% | 137,955株 | +3.83% | 17,682株 | -79.74% |
2017/10/13 | 日証協 | 314,861株 | +50.38% | 151,961株 | +29.44% | 132,872株 | -11.99% | 87,264株 | +134.06% |
2017/10/06 | 日証協 | 209,378株 | +60.28% | 117,398株 | +33.86% | 150,972株 | +10.56% | 37,282株 | -72.41% |
2017/09/29 | 日証協 | 130,630株 | -36.66% | 87,700株 | +6.23% | 136,548株 | -2.68% | 135,148株 | +436.3% |
2017/09/22 | 日証協 | 206,243株 | -29.69% | 82,559株 | -42.13% | 140,306株 | -31.94% | 25,200株 | -72.5% |
2017/09/15 | 日証協 | 293,326株 | -6.31% | 142,656株 | +71.47% | 206,157株 | -1.07% | 91,635株 | +136.91% |
2017/09/08 | 日証協 | 313,095株 | -8.06% | 83,198株 | -7.47% | 208,384株 | -1.13% | 38,680株 | -57.8% |
2017/09/01 | 日証協 | 340,533株 | -3.96% | 89,910株 | -29.08% | 210,767株 | +5.19% | 91,650株 | +74.16% |
2017/08/25 | 日証協 | 354,570株 | -18.01% | 126,771株 | -11.05% | 200,367株 | -28.43% | 52,625株 | -45.61% |
2017/08/18 | 日証協 | 432,439株 | -2.23% | 142,518株 | +96.99% | 279,952株 | +10.23% | 96,755株 | +5.33% |
2017/08/10 | 日証協 | 442,282株 | -0.03% | 72,346株 | +540.23% | 253,976株 | -3.53% | 91,859株 | +66.68% |
2017/08/04 | 日証協 | 442,412株 | -5.49% | 11,300株 | -93.32% | 263,283株 | +3.01% | 55,111株 | +65.45% |
2017/07/28 | 日証協 | 468,130株 | +11.39% | 169,278株 | +583.37% | 255,581株 | -1.5% | 33,309株 | +78.63% |
2017/07/21 | 日証協 | 420,275株 | +2.19% | 24,771株 | -83.06% | 259,463株 | -4.2% | 18,647株 | -74.23% |
2017/07/14 | 日証協 | 411,272株 | -9.34% | 146,185株 | -42.98% | 270,841株 | +4.59% | 72,349株 | +32.85% |
※株式分割は考慮していませんのでご注意ください。
Page Top